Richtlijn: Hartafwijkingen (2017)


Andermann A, Blancquaert I, Beauchamp S, Déry V. Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years. Bulletin of the World Health Organisation 2008;86:317-319.

Anderson JB, Grenier M, Edwards NM, Madsen NL, Czosek RJ, Spar DS, Barnes A, Pratt J, King E, Knilans TK. Usefulness of combined history, physical examination, electrocardiogram, and limited echocardiogram in screening adolescent athletes for risk for sudden cardiac death. Am J Cardiol 2014;114:1763-1767 (a).

Anderson BR, McElligott S, Polsky D, Vetter VL. Electrocardiographic screening for hypertrophic cardiomyopathy and long QT syndrome: the drivers of cost-effectiveness for the prevention of sudden cardiac death. Pediatr Cardiol 2014;35:323-331 (b).

Behera SK, Pattnaik T, Luke A. Practical recommendations and perspectives on cardiac screening for healthy pediatric athletes. Curr.Sports Med.Rep. 2011 Mar-Apr;10(2):90-98.

Briedé S, Hamoun M, Oosterveld MJS, Breur JMPJ. Langetermijneffecten van de ziekte van Kawasaki. Ned Tijdsch Geneeskd 2010;154:A2121.

Chandra N, Bastiaenen R, Papadakis M, Panoulas VF, Ghani S, Duschl J, Foldes D, Raju H, Osborne R, Sharma S. Prevalence of electrocardiographic anomalies in young individuals: relevance to a nationwide cardiac screening program. J Am Coll Cardiol 2014;63:2028-2034.

Engelfriet PM, van Gils PF, Smit HA. Preparticipatiescreening om plotse dood te voorkomen: Italian design voor Nederlandse sporters? RIVM, 2009.

Hurst D, Hirsh DA, Oster ME, Ehrlich A, Campbell R, Mahle WT, Mallory M, Phelps H. Syncope in the Pediatric Emergency Department - Can We Predict Cardiac Disease Based on History Alone? J Emerg Med. 2015 Jul;49(1):1-7.

Kane A, Mirabel M, Toure K, Perier MC, Fazaa S, Tafflet M, Karam N, Zourak I, Diagne D, Mbaye A, Kane M, Diack B, Jouven X, Marijon E. Echocardiographic screening for rheumatic heart disease: age matters. Int J Cardiol 2013;168:888-891.

Kavey RE, Allada V, Daniels SR, Hayman LL, McCrindle BW, Newburger JW, Parekh RS, Steinberger J; American Heart Association Expert Panel on Population and Prevention Science; American Heart Association Council on Cardiovascular Disease in the Young; American Heart Association Council on Epidemiology and Prevention; American Heart Association Council on Nutrition, Physical Activity and Metabolism; American Heart Association Council on High Blood Pressure Research; American Heart Association Council on Cardiovascular Nursing; American Heart Association Council on the Kidney in Heart Disease; Interdisciplinary Working Group on Quality of Care and Outcomes Research. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation 2006;114:2710-38.

Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB. Contemporary definitions and classification of the cardiomyopathies. Circulation 2006;113;1807-1816.

Maron BJ, Thompson PD, Ackerman MJ, Balady G, Berger S, Cohen D, Dimeff R, Douglas PS, Glover DW, Hutter AM Jr, Krauss MD, Maron MS, Mitten MJ, Roberts WO, Puffer JC; American Heart Association Council on Nutrition, Physical Activity, and Metabolism. Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism. Circulation 2007;115:1643–55.

Maron BJ, Friedman RA, Kligfield P, Levine BD, Viskin S, Chaitman BR, Okin PM, Saul JP, Salberg L, Van Hare GF, Soliman EZ, Chen J, Matherne GP, Bolling SF, Mitten MJ, Caplan A, Balady GJ, Thompson PD; American Heart Association Council on Clinical Cardiology; Advocacy Coordinating Committee; Council on Cardiovascular Disease in the Young; Council on Cardiovascular Surgery and Anesthesia; Council on Epidemiology and Prevention; Council on Functional Genomics and Translational Biology; Council on Quality of Care and Outcomes Research, and American College of Cardiology. Assessment of the 12-lead electrocardiogram as a screening test for detection of cardiovascular disease in healthy general populations of young people (12-25 years of age): a scientific statement from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol 2014;64:1479-1514.

Movahed MR, Strootman D, Bates S, Sattur S. Prevalence of suspected hypertrophic cardiomyopathy or left ventricular hypertrophy based on race and gender in teenagers using screening echocardiography. Cardiovasc Ultrasound 2010;8:54.

Ng CT, Ong HY, Cheok C, Chua TS, Ching CK. Prevalence of electrocardiographic abnormalities in an unselected young male multi-ethnic South-East Asian population undergoing pre-participation cardiovascular screening: results of the Singapore Armed Forces Electrocardiogram and Echocardiogram screening protocol. Europace 2012;14:1018-1024.

Ostman-Smith I, Rossano JW, Shaddy RE. Hypertrophic cardiomyopathy: do sudden death prevention strategies in children differ between Europe and North America? Curr Opin Cardiol 2013;28:130-138.

Saul JP, Schwartz PJ, Ackerman MJ, Triedman JK. Rationale and objectives for ECG screening in infancy. Heart Rhythm 2014;11:2316-21.

Skinner JR, Van Hare GF. Routine ECG screening in infancy and early childhood should not be performed. Heart Rhythm 2014;11:2322-7.

Task Force for the Diagnosis and Management of Syncope; European Society of Cardiology (ESC); European Heart Rhythm Association (EHRA); Heart Failure Association (HFA); Heart Rhythm Society (HRS), Moya A, Sutton R, Ammirati F, Blanc JJ, Brignole M, Dahm JB, Deharo JC, Gajek J, Gjesdal K, Krahn A, Massin M, Pepi M, Pezawas T, Ruiz Granell R, Sarasin F, Ungar A, van Dijk JG, Walma EP, Wieling W. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J 2009;30:2631-71.

Tsuji T, Suzuki J, Shimamoto R, Yamazaki T, Ohomoto Y, Iwasawa K, Nagai R. Morbidity prevalence rate of kawasaki disease assessed by single cross-sectional history-taking. Int Heart J 2007;48:615-621.

Vetter VL, Dugan N, Guo R, Mercer-Rosa L, Gleason M, Cohen M, Vogel RL, Iyer R. A pilot study of the feasibility of heart screening for sudden cardiac arrest in healthy children. Am Heart J 2011;161:1000-1006.

Vetter VL, Dugan NP. A discussion of electrocardiographic screening and sudden cardiac death prevention: evidence and consensus. Curr Opin Cardiol 2013;28:139-151.

Wilson JMG, Jungner G. Principles and practice of screening for disease. Geneva: WHO, 1968.

Wilson MG, Basavarajaiah S, Whyte GP, Cox S, Loosemore M, Sharma S. Efficacy of personal symptom and family history questionnaires when screening for inherited cardiac pathologies: the role of electrocardiography. Br J Sports Med 2008;42:207-211.

Witsenburg M, Strengers JLM, van Osch-Gevers M. Praktische kindergeneeskunde: Kindercardiologie. Bohn Stafleu van Loghum, 2005.

World Health Organisation (WHO). Rheumatic fever and rheumatic heart disease : report of a WHO Expert Consultation World Health Organ Tech Rep Ser 2004;923:1-122.

Pagina als PDF